Xavier Gaume

2PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 04, 2026
Eneboparatide induces prolonged 24-hour PTH 1 receptor activation.

|Mar 11, 2025
Additive effects of ALXN2420, a GH receptor antagonist, and octreotide on IGF1 suppression in vivo.

Guillaume Ravel, Xavier Gaume, Corentin Berardet

Pageof 1

Frequent Collaborators

1 joint publications

Clémentine Chalmey